DIVIS LABORATORIES Announces Quarterly Results (3QFY21); Net Profit Up 27.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 14th April, 2021 on account of Dr. Baba Saheb Ambedkar Jayanti.

DIVIS LABORATORIES Announces Quarterly Results (3QFY21); Net Profit Up 27.9%
Wed, 10 Feb

DIVIS LABORATORIES has announced its results for the quarter ended December 2020. Here is a detailed performance review of the same:

DIVIS LABORATORIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-19*
3
Sep-20*
3
Dec-20*
QoQ ChangeYoY Change
Net SalesRs m13,90517,13816,565-3.3%19.1%
Other incomeRs m40313619744.3%-51.2%
TurnoverRs m14,30817,27416,762-3.0%17.1%
ExpensesRs m8,9369,8149,780-0.3%9.4%
Gross profitRs m4,9697,3246,785-7.4%36.5%
DepreciationRs m46760968011.6%45.5%
InterestRs m1612100.0%-85.8%
Profit before taxRs m4,8896,8506,300-8.0%28.8%
TaxRs m1,2821,7171,687-1.8%31.6%
Profit after taxRs m3,6075,1334,612-10.1%27.9%
Gross profit margin%35.742.741.0
Effective tax rate%26.225.126.8
Net profit margin%25.229.727.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 19.1% on a year-on-year (YoY) basis. The expenses were up by 9.4% YoY during the same period.
  • The company's operating profit increased by 36.5% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 41.0% in 3QFY21 as against 35.7% in 3QFY20.
  • Depreciation charges increased by 45.5% and finance costs declined by 85.8% YoY, respectively.
  • Other income declined by 51.2% YoY during the quarter.
  • Net profit for the quarter increased by 27.9% YoY. Net profit margins during the quarter increased from 25.2% in 3QFY20 to 27.5% in 3QFY21.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 3.3% on a quarter-on-quarter (QoQ) basis. The expenses were down by 0.3% QoQ during the same period.
  • The company's operating profit declined by 7.4% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 41.0% in 3QFY21 as against 42.7% in 2QFY20.
  • Net profit for the quarter declined by 10.1% QoQ, while net profit margins declined from 29.7% in 2QFY20 to 27.5% in 3QFY21.

To see how DIVIS LABORATORIES has performed over the last eight quarters,please visit here.

Revealed: 3 Stocks for Potentially Massive Gains

DIVIS LABORATORIES Share Price Performance

Over the last one year, DIVIS LABORATORIES share price has moved up from Rs 2,088.0 to Rs 3,710.0, registering a Gain of Rs 1,622.0 or around 77.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 21,730.8 (down 0.2%). Over the last one year it has moved up from 14,241.2 to 21,730.8, a gain of 7,490 points (up 52.6%).

Overall, the S&P BSE SENSEX is up 24.9% over the year.

Current Valuations

At the current price of Rs 3,710.0, the price to earnings (P/E) ratio of DIVIS LABORATORIES stands at 53.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 14.2 times.

Equitymaster requests your view! Post a comment on "DIVIS LABORATORIES Announces Quarterly Results (3QFY21); Net Profit Up 27.9%". Click here!

  

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4% (Quarterly Result Update)

Jun 8, 2020 | Updated on Jun 8, 2020

For the quarter ended March 2020, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 35.4% YoY). Sales on the other hand came in at Rs 14 bn (up 9.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This...(Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

The Indian Real Estate Party Has Just Begun(Profit Hunter)

Apr 1, 2021

A favourable demand supply scenario makes a strong case for real estate prices.

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

The Dilemma of Investing in Bharti Airtel(Views On News)

Apr 1, 2021

Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Apr 13, 2021 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS